FierceBiotechOriginal article
{"a":[{"_":"PDS halts work on phase 3 cancer therapy to focus on colorectal contender","$":{"href":"/biotech/pds-halts-phase-3-stage-cancer-therapy-focus-colorectal-contender","hreflang":"en"}}]}
Negative
AI Analysis
Summary
PDS Biotechnology has discontinued its Phase 3 head and neck cancer therapy program to redirect resources toward a Phase 2 metastatic colorectal cancer candidate.
Outcome Details
Phase 3 program halted; resources redirected to Phase 2 colorectal cancer program
Importance:5/10
Sentiment:
-0.60
Phase 3 haltoncologyresource allocationprogram discontinuation
Related Companies
Read the original article
Published by FierceBiotech on August 13, 2026 9:56 AM